AAM Speaks Out Against Build Back Better Bill

US Pricing Policy Could Unfairly Penalize Generics And Biosimilars Manufacturers

23 Nov 2021

The US Association for Accessible Medicines has panned the Biden administration’s Build Back Better Act, which it says threatens patient access to affordable drugs in its current form.

Joe Biden Build Back Better — Biden's Build Back Better Bill Has Been Criticized By The AAM • Source: Alamy

The US Association for Accessible Medicines has spoken out against the Build Back Better Act, saying it “threatens the only segment of our health care system that consistently drives prices down for patients.”

The Act was passed in the US House of Representatives on 19 November and now faces an uphill battle to...